Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02383927
Title Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Kura Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | BEL

Additional content available in CKB BOOST